Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Sleep Med. 2019 Jan 11;59:114–116. doi: 10.1016/j.sleep.2019.01.004

Table 1.

Adherence data from the first 90 days of therapy.

Adherence measures Values (n = 2,621,182)
Median (IQR)a

CMS compliance in first 90 days, n (%) 1,955,961 (74.6)
Time to achieve CMS compliance, days 23.00 (21.00, 27.00)
Device usage, h/session 6.18 (4.79, 7.35)
Daily usage (all days), h/night 5.54 (3.42, 7.04)
Proportion of days with non-zero usage, % 93.3 (72.2, 98.9)
Proportion of days compliant (usage ≥ 4 h/night), % 80.0 (46.7, 95.6)

CMS, Center for Medicare and Medicaid Services; IQR, interquartile range; SD, standard deviation. CMS Compliance definition: ≥4 hours’ PAP use on 70% of nights in a consecutive 30-day period in the first 90 days of therapy.

a

Data not normally distributed.

HHS Vulnerability Disclosure